Logo image of SMTI

SANARA MEDTECH INC (SMTI) Stock Fundamental Analysis

NASDAQ:SMTI - Nasdaq - US79957L1008 - Common Stock - Currency: USD

29.68  -0.72 (-2.37%)

After market: 29.43 -0.25 (-0.84%)

Fundamental Rating

3

Overall SMTI gets a fundamental rating of 3 out of 10. We evaluated SMTI against 187 industry peers in the Health Care Equipment & Supplies industry. The financial health of SMTI is average, but there are quite some concerns on its profitability. While showing a medium growth rate, SMTI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

SMTI had negative earnings in the past year.
In the past year SMTI has reported a negative cash flow from operations.
In the past 5 years SMTI always reported negative net income.
In the past 5 years SMTI always reported negative operating cash flow.
SMTI Yearly Net Income VS EBIT VS OCF VS FCFSMTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M -8M -10M

1.2 Ratios

SMTI has a Return On Assets of -11.86%. This is comparable to the rest of the industry: SMTI outperforms 59.36% of its industry peers.
SMTI's Return On Equity of -31.16% is in line compared to the rest of the industry. SMTI outperforms 55.08% of its industry peers.
Industry RankSector Rank
ROA -11.86%
ROE -31.16%
ROIC N/A
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.7%
ROE(5y)-29.97%
ROIC(3y)N/A
ROIC(5y)N/A
SMTI Yearly ROA, ROE, ROICSMTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

1.3 Margins

SMTI has a Gross Margin of 91.17%. This is amongst the best in the industry. SMTI outperforms 99.47% of its industry peers.
In the last couple of years the Gross Margin of SMTI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for SMTI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 91.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
SMTI Yearly Profit, Operating, Gross MarginsSMTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

SMTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SMTI has more shares outstanding
The number of shares outstanding for SMTI has been increased compared to 5 years ago.
SMTI has a worse debt/assets ratio than last year.
SMTI Yearly Shares OutstandingSMTI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
SMTI Yearly Total Debt VS Total AssetsSMTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 3.21 indicates that SMTI is not in any danger for bankruptcy at the moment.
SMTI has a better Altman-Z score (3.21) than 68.98% of its industry peers.
SMTI has a Debt/Equity ratio of 1.18. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SMTI (1.18) is worse than 81.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Altman-Z 3.21
ROIC/WACCN/A
WACC8.73%
SMTI Yearly LT Debt VS Equity VS FCFSMTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

SMTI has a Current Ratio of 2.77. This indicates that SMTI is financially healthy and has no problem in meeting its short term obligations.
SMTI's Current ratio of 2.77 is in line compared to the rest of the industry. SMTI outperforms 54.55% of its industry peers.
A Quick Ratio of 2.54 indicates that SMTI has no problem at all paying its short term obligations.
SMTI has a Quick ratio (2.54) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.77
Quick Ratio 2.54
SMTI Yearly Current Assets VS Current LiabilitesSMTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for SMTI have decreased strongly by -48.97% in the last year.
The Revenue has grown by 33.36% in the past year. This is a very strong growth!
SMTI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 49.08% yearly.
EPS 1Y (TTM)-48.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.9%
Revenue 1Y (TTM)33.36%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%28.13%

3.2 Future

SMTI is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -11.52% yearly.
The Revenue is expected to grow by 17.21% on average over the next years. This is quite good.
EPS Next Y-39.58%
EPS Next 2Y-11.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year20.98%
Revenue Next 2Y17.21%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SMTI Yearly Revenue VS EstimatesSMTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
SMTI Yearly EPS VS EstimatesSMTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SMTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SMTI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SMTI Price Earnings VS Forward Price EarningsSMTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMTI indicates a somewhat cheap valuation: SMTI is cheaper than 60.43% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 585.82
SMTI Per share dataSMTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as SMTI's earnings are expected to decrease with -11.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.52%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SMTI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SANARA MEDTECH INC

NASDAQ:SMTI (8/15/2025, 8:00:02 PM)

After market: 29.43 -0.25 (-0.84%)

29.68

-0.72 (-2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-13 2025-08-13/bmo
Earnings (Next)11-10 2025-11-10
Inst Owners11.57%
Inst Owner Change-1.32%
Ins Owners8.45%
Ins Owner Change0.72%
Market Cap263.86M
Analysts82.5
Price Target49.98 (68.4%)
Short Float %7.82%
Short Ratio5.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.72%
Min EPS beat(2)-53.45%
Max EPS beat(2)20.02%
EPS beat(4)2
Avg EPS beat(4)-19.65%
Min EPS beat(4)-91.41%
Max EPS beat(4)46.24%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.09%
Min Revenue beat(2)-2.13%
Max Revenue beat(2)-0.04%
Revenue beat(4)2
Avg Revenue beat(4)0.98%
Min Revenue beat(4)-2.13%
Max Revenue beat(4)3.47%
Revenue beat(8)3
Avg Revenue beat(8)-2.22%
Revenue beat(12)5
Avg Revenue beat(12)-2.2%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.28%
EPS NY rev (1m)0%
EPS NY rev (3m)12.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.88
P/FCF N/A
P/OCF N/A
P/B 7.2
P/tB N/A
EV/EBITDA 585.82
EPS(TTM)-1.16
EYN/A
EPS(NY)-1.42
Fwd EYN/A
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS10.3
BVpS4.12
TBVpS-1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.86%
ROE -31.16%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 91.17%
FCFM N/A
ROA(3y)-9.93%
ROA(5y)-19.18%
ROE(3y)-17.7%
ROE(5y)-29.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.07%
GM growth 5Y0.2%
F-Score3
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF N/A
Debt/EBITDA 86.79
Cap/Depr 38.17%
Cap/Sales 2.06%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.77
Quick Ratio 2.54
Altman-Z 3.21
F-Score3
WACC8.73%
ROIC/WACCN/A
Cap/Depr(3y)14.51%
Cap/Depr(5y)146.81%
Cap/Sales(3y)0.77%
Cap/Sales(5y)3.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.9%
EPS Next Y-39.58%
EPS Next 2Y-11.52%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)33.36%
Revenue growth 3Y53.13%
Revenue growth 5Y49.08%
Sales Q2Q%28.13%
Revenue Next Year20.98%
Revenue Next 2Y17.21%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.11%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y91.73%
OCF growth 3YN/A
OCF growth 5YN/A